124I
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 124I, covering 2022-03-29 to 2022-03-29. Get the full timeline:
Most recent: Clinical Trial Update: Metastatic Thyroid Cancer Therapy Optimization With 124I PET Dosimetry [Phase 2]